PubMed HealthSearch

Biomedical subjects

B Bouchité

Publications and source records attributed to B Bouchité.

3 recordsLinked to original sources

[Study of the distribution of human filariasis in West Province of Cameroon].

A clinical and parasitological survey of onchocerciasis and loiasis has been carried out in 38 communities in the West Province of Cameroon prior to the implementation of a mass ivermectin treatment. The highest endemicity levels of onchocerciasis were recorded in the villages located at an altitude below 1400 m, and whose inhabitants go down to the valleys for agricultural activities. Conversely, low endemicity levels were recorded in the most populated part of the study area, which is located at an altitude above 1400 m; in the latter communities, the residents cultivate the high ground not far from their houses and are thus less exposed to transmission of onchocerciasis. Despite relatively low microfilarial loads, the prevalences of nodules were fairly high; this demonstrates that in some epidemiological situations the latter indicator gives an erroneous indication of the intensity of infection in the population. The prevalence of loiasis is very low in most of the villages of the study area.

Agriculture

Impact of repeated large scale ivermectin treatments on the transmission of Loa loa.

We have studied the impact of large-scale treatment with ivermectin on the transmission of loiasis in a forest village in south Cameroon where loiasis was highly endemic, with a prevalence of 30%. After one year of parasitological and entomological surveillance without treatment, all consenting residents aged > 5 years received ivermectin 200 micrograms/kg every 3 months. For ethical reasons, treatment was interrupted after 2 years, but parasitological and entomological surveillance continued for 18 months after the end of treatment. The prevalence of loiasis was reduced to < 10% and the mean microfilaraemia decreased by 90% in 2 years. The prevalence and average intensity of infection remained stable during the 18 months after treatment ended. Two vector species were identified, Chrysops dimidiata (representing about 90% of the fly population) and C. silacea. The infection rate (all stages) in Chrysops decreased by 75% and the infective rate (percentage of Chrysops harbouring third-stage larvae of Loa loa in the head) decreased by 85% in C. dimidiata and became zero in C. silacea. After the end of treatment, the infection and infective rates increased gradually. Large-scale treatment seemed an efficient method for the control of L. loa transmission provided high drug coverage was achieved. Nevertheless, because of the high risk of adverse effects when using the current microfilaricidal drugs, such a strategy remains unacceptable.

Animals